Approvals/CIMA-AEMPS/TEMYBRIC ELLIPTA 92 MICROGRAMOS/55 MICROGRAMOS/22 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS)

Approved

STANDARD

TEMYBRIC ELLIPTA 92 MICROGRAMOS/55 MICROGRAMOS/22 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS)

Glaxosmithkline Trading Services Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: efe3120cc389112a
Drug Cima Aemps Name: TEMYBRIC ELLIPTA 92 MICROGRAMOS/55 MICROGRAMOS/22 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS)
Register Number: 1191378002
Holder Company Name: Glaxosmithkline Trading Services Limited
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-trading-services-limited
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2021-08-31
Dosage Form: POLVO PARA INHALACIÓN (UNIDOSIS)
Dose: 92 microgramos/55 microgramos/22 microgramos
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Glaxosmithkline Trading Services Limited
Company Detail Path: /organization/glaxosmithkline-trading-services-limited

FLUTICASONA FUROATO

0,092 mg

UMECLIDINIO BROMURO

0,065 mg

VILANTEROL TRIFENATATO

0,022 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 31, 2021

Approval ID

efe3120cc389112a

Type

Standard